Year: 2023

Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)

Company Announcement The positive CHMP opinion is supported by results from the EPCORE™ NHL-1 phase 1/2 trial evaluating the preliminary...

Molecure completes successful Secondary Public Offering (SPO) of approximately PLN 50 million (USD 12 million) with proceeds to be used to fund and build a first in class, sustainable pipeline of breakthrough therapies

Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

LevelUp MD Urgent Care Appoints Dr. Paul Kim as New CEO, Spearheading Affordable Healthcare and Combating Disparities in NY and NJ Region

RIDGEFIELD PARK, N.J.--(BUSINESS WIRE)--LevelUp MD Urgent Care, a renowned provider of high-quality urgent care services, proudly announces the appointment of...

Encore Health Group and Affiliates Experiences Significant Success with eClinicalWorks V12 and healow Patient Engagement Solutions

Chronic pain management provider utilizes digital health IT solutions across the organization for improved workflowsWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory...

error: Content is protected !!